Business Standard

Sun Pharma surges; unit Taro beats July-Sept analysts' estimates

Image

Reuters

Reuters Markete Eye - Sun Pharmaceutical Industries Ltd gains 3 percent after its unit Taro Pharmaceutical Industries Ltd operational earnings beat some analysts estimates.

Taro's quarterly earnings per share came at $2.15 while sales rose 27.5 percent to $205.3 million.

Analysts say a price hike in certain product categories by Taro led to the operating earnings beat while also boosting outlook for Sun Pharmaceutical's earnings results later in the day.

(Reporting by Abhishek Vishnoi)

Don't miss the most important news and views of the day. Get them on our Telegram channel

First Published: Nov 13 2013 | 10:23 AM IST

Explore News